Substance

MONALIZUMAB

Global reference: every product and company linked to this substance.

Anti-NKG2A · HUMZ270 · IPH-2201 (ANTI-NKG2A) · IPH2201 · monalizumab [INN] · MONALIZUMAB [USAN] · Monalizumab [WHO-DD] · NN-8765 · NN8765 · NN8765-3658 · NNC0141-0000-0100 · NNC0141-0100

Revenue by product (0)

No revenue reported for this substance in loaded filings.

A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.

Products containing this substance (0)

    Companies holding this asset (1)